These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 18848459)
1. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules. Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
3. Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma? Hagi T; Nakamura T; Sugino Y; Matsubara T; Asanuma K; Sudo A Anticancer Res; 2018 Jun; 38(6):3635-3639. PubMed ID: 29848720 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082 [TBL] [Abstract][Full Text] [Related]
5. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET. Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
7. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
8. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584 [TBL] [Abstract][Full Text] [Related]
9. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088 [TBL] [Abstract][Full Text] [Related]
10. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090 [TBL] [Abstract][Full Text] [Related]
11. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Aquino SL; Kuester LB; Muse VV; Halpern EF; Fischman AJ Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):692-6. PubMed ID: 16514531 [TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT. Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020 [TBL] [Abstract][Full Text] [Related]
14. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? Kim TJ; Park CM; Goo JM; Lee KW AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482 [TBL] [Abstract][Full Text] [Related]
15. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626 [TBL] [Abstract][Full Text] [Related]
16. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730 [TBL] [Abstract][Full Text] [Related]
19. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule]. Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792 [TBL] [Abstract][Full Text] [Related]